Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashish Ranjan Dwivedi

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|August 20, 2015
Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A ReviewRamandeep Kaur, Ashish Ranjan Dwivedi, Bhupinder Kumar, et al.
Chemmedchem|March 14, 2018
Synthesis, Biological Evaluation and Molecular Modeling Studies of Propargyl-Containing 2,4,6-Trisubstituted Pyrimidine Derivatives as Potential Anti-Parkinson AgentsBhupinder Kumar, Mohit Kumar, Ashish Ranjan Dwivedi, et al.
Current Medicinal Chemistry|May 13, 2021
Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer's DiseaseBhupinder Kumar, Amandeep Thakur, Ashish Ranjan Dwivedi, et al.
Current Drug Targets|August 22, 2019
Targeting Cancer Stem Cells Pathways for the Effective Treatment of CancerAshish Ranjan Dwivedi, Amandeep Thakur, Vijay Kumar, et al.
Bioorganic & Medicinal Chemistry|April 10, 2022
Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's diseaseNaveen Kumar, Vijay Kumar, Piyush Anand, et al.
Current Medicinal Chemistry|July 18, 2020
Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Different Disease States: Recent UpdatesSuvadeep Mal, Ashish Ranjan Dwivedi, Vijay Kumar, et al.
RSC Medicinal Chemistry|June 13, 2022
Morpholine substituted quinazoline derivatives as anticancer agents against MCF-7, A549 and SHSY-5Y cancer cell lines and mechanistic studiesAshish Ranjan Dwivedi, Vijay Kumar, Vikash Prashar, et al.
Current Drug Delivery|September 18, 2024
Exploring the Insights on Exosomes and their Utility in Treating Ophthalmic Disease: Delving into the Clinical Approval and Present TrialsAshish Ranjan Dwivedi, Yogesh Murti, Pramod Rawat, et al.
Clinical and Translational Science|April 22, 2025
Promising New Anti-TIGIT Agents: Stealthy Allies in Cancer ImmunotherapyGatadi Srikanth, Durga Prasad Beda, Ashish Ranjan Dwivedi, et al.
Journal of Biomolecular Structure & Dynamics|April 28, 2023
Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer's diseaseKailash Jangid, Bharti Devi, Ashrulochan Sahoo, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Anti-Cancer Agents in Medicinal Chemistry|August 20, 2015
Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A ReviewRamandeep Kaur, Ashish Ranjan Dwivedi, Bhupinder Kumar, et al.
Chemmedchem|March 14, 2018
Synthesis, Biological Evaluation and Molecular Modeling Studies of Propargyl-Containing 2,4,6-Trisubstituted Pyrimidine Derivatives as Potential Anti-Parkinson AgentsBhupinder Kumar, Mohit Kumar, Ashish Ranjan Dwivedi, et al.
Current Medicinal Chemistry|May 13, 2021
Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer's DiseaseBhupinder Kumar, Amandeep Thakur, Ashish Ranjan Dwivedi, et al.
Current Drug Targets|August 22, 2019
Targeting Cancer Stem Cells Pathways for the Effective Treatment of CancerAshish Ranjan Dwivedi, Amandeep Thakur, Vijay Kumar, et al.
Bioorganic & Medicinal Chemistry|April 10, 2022
Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's diseaseNaveen Kumar, Vijay Kumar, Piyush Anand, et al.
Current Medicinal Chemistry|July 18, 2020
Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Different Disease States: Recent UpdatesSuvadeep Mal, Ashish Ranjan Dwivedi, Vijay Kumar, et al.
RSC Medicinal Chemistry|June 13, 2022
Morpholine substituted quinazoline derivatives as anticancer agents against MCF-7, A549 and SHSY-5Y cancer cell lines and mechanistic studiesAshish Ranjan Dwivedi, Vijay Kumar, Vikash Prashar, et al.
Current Drug Delivery|September 18, 2024
Exploring the Insights on Exosomes and their Utility in Treating Ophthalmic Disease: Delving into the Clinical Approval and Present TrialsAshish Ranjan Dwivedi, Yogesh Murti, Pramod Rawat, et al.
Clinical and Translational Science|April 22, 2025
Promising New Anti-TIGIT Agents: Stealthy Allies in Cancer ImmunotherapyGatadi Srikanth, Durga Prasad Beda, Ashish Ranjan Dwivedi, et al.
Journal of Biomolecular Structure & Dynamics|April 28, 2023
Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer's diseaseKailash Jangid, Bharti Devi, Ashrulochan Sahoo, et al.
Pageof 4